The FRY gene identification publication, and every other announcement the company made.
Technology news
GeneAssess, Inc. is delighted to announce the publication of the study identifying FRY as a candidate mammary carcinoma susceptibility gene. This is the announcement the company carried on its own homepage.
Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene. Ren X, Graham JC, Jing L, Mikheev AM, Gao Y, Lew JP, Xie H, Kim AS, Shang X, Friedman C, Vail G, Fang MZ, Bromberg Y, Zarbl H. PLoS ONE 8(9): e70930.
Press releases and publications
Four records, each with a live link to a source that can be checked.
2013
PLoS ONE 8(9): e70930 · Ren X, Graham JC, Jing L, Mikheev AM, Gao Y, Lew JP, Xie H, Kim AS, Shang X, Friedman C, Vail G, Fang MZ, Bromberg Y, Zarbl H
The paper that identified FRY. Open access under a Creative Commons Attribution licence.
2012
Global Corporate Venturing, 4 July 2012
The company’s first disclosed financing, alongside the founder’s description of FRY as a potential platform for susceptibility tests, progression tests and tumour grading.
2012
FinSMEs, July 2012
Trade-press coverage of the same round.
2020
Frontiers in Oncology 9:1279 · Liu Y, Chen X, Gong Z, Zhang H, Fei F, Tang X, Wang J, Xu P, Zarbl H, Ren X
Later work from the same programme, using conditional knockout mice. Open access under a Creative Commons Attribution licence.
